Joel N. Blankson

Joel N. Blankson is a professor at the Johns Hopkins School of Medicine in the Department of Medicine, Division of Infectious Diseases. Blankson is an expert on HIV infection, particularly HIV latency and long-term control of HIV infection. He is a lead investigator in studies on these topics and is frequently interviewed in the scientific and popular press. Blankson also practices internal and infectious diseases medicine in Lutherville, Maryland. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Joel N. Blankson', query time: 0.02s Refine Results
  1. 1
    CD4+ T cell recognition of HIV-1 alternate reading frame proteins

    CD4+ T cell recognition of HIV-1 alternate reading frame proteins by Joel Sop, Tyler P. Beckey, Joel N. Blankson

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron

    Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron by Andrew H. Karaba, Jiashu Xue, Trevor S. Johnston, Caroline C. Traut, Lorien S. Dalrymple, Robert J. Kossmann, Joel N. Blankson, Chirag R. Parikh, Stuart C. Ray

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells

    The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells by Joel Sop, Alicia Mercado, Alexis Figueroa, Tyler P. Beckey, Caroline C. Traut, Li Zhang, Li Zhang, Kellie N. Smith, Kellie N. Smith, Joel N. Blankson

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching

    A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching by Jenny M. Lee, Jaiprasath Sachithanandham, John S. Lee, Janna R. Shapiro, Maggie Li, Ioannis Sitaris, Stephanie R. Peralta, Camille Wouters, Andrea L. Cox, Dorry L. Segev, Christine M. Durand, Mark Robien, Aaron A. R. Tobian, Andrew H. Karaba, Joel N. Blankson, William A. Werbel, Andrew Pekosz, Sabra L. Klein

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: